86 related articles for article (PubMed ID: 7907869)
1. Different sensitivity of alpha 2A-C10 and alpha 2C-C4 receptor subtypes in coupling to inhibition of cAMP accumulation.
Jansson CC; Savola JM; Akerman KE
Biochem Biophys Res Commun; 1994 Mar; 199(2):869-75. PubMed ID: 7907869
[TBL] [Abstract][Full Text] [Related]
2. Selective coupling of alpha 2-adrenergic receptor subtypes to cyclic AMP-dependent reporter gene expression in transiently transfected JEG-3 cells.
Pepperl DJ; Regan JW
Mol Pharmacol; 1993 Oct; 44(4):802-9. PubMed ID: 8232231
[TBL] [Abstract][Full Text] [Related]
3. Binding and functional characterization of alpha-2 adrenergic receptor subtypes on pig vascular endothelium.
Bockman CS; Jeffries WB; Abel PW
J Pharmacol Exp Ther; 1993 Dec; 267(3):1126-33. PubMed ID: 7903385
[TBL] [Abstract][Full Text] [Related]
4. alpha2C adrenoceptors inhibit adenylyl cyclase in mouse striatum: potential activation by dopamine.
Zhang W; Klimek V; Farley JT; Zhu MY; Ordway GA
J Pharmacol Exp Ther; 1999 Jun; 289(3):1286-92. PubMed ID: 10336518
[TBL] [Abstract][Full Text] [Related]
5. Nitric oxide attenuates alpha(2)-adrenergic receptors by ADP-ribosylation of G(i)alpha in ciliary epithelium.
Moroi SE; Hao Y; Sitaramayya A
Invest Ophthalmol Vis Sci; 2001 Aug; 42(9):2056-62. PubMed ID: 11481272
[TBL] [Abstract][Full Text] [Related]
6. HepG2 and SK-N-MC: two human models to study alpha-2 adrenergic receptors of the alpha-2C subtype.
Schaak S; Cayla C; Blaise R; Quinchon F; Paris H
J Pharmacol Exp Ther; 1997 May; 281(2):983-91. PubMed ID: 9152409
[TBL] [Abstract][Full Text] [Related]
7. Cloning and expression of the alpha 2C-adrenergic receptor from the OK cell line.
Blaxall HS; Cerutis DR; Hass NA; Iversen LJ; Bylund DB
Mol Pharmacol; 1994 Feb; 45(2):176-81. PubMed ID: 7509437
[TBL] [Abstract][Full Text] [Related]
8. Coupling of I(1) imidazoline receptors to the cAMP pathway: studies with a highly selective ligand, benazoline.
Greney H; Ronde P; Magnier C; Maranca F; Rascente C; Quaglia W; Giannella M; Pigini M; Brasili L; Lugnier C; Bousquet P; Dontenwill M
Mol Pharmacol; 2000 Jun; 57(6):1142-51. PubMed ID: 10825384
[TBL] [Abstract][Full Text] [Related]
9. Alpha-2 adrenoceptor subtype causing nitric oxide-mediated vascular relaxation in rats.
Bockman CS; Gonzalez-Cabrera I; Abel PW
J Pharmacol Exp Ther; 1996 Sep; 278(3):1235-43. PubMed ID: 8819507
[TBL] [Abstract][Full Text] [Related]
10. Cultured human trabecular meshwork cells express functional alpha 2A adrenergic receptors.
Stamer WD; Huang Y; Seftor RE; Svensson SS; Snyder RW; Regan JW
Invest Ophthalmol Vis Sci; 1996 Nov; 37(12):2426-33. PubMed ID: 8933759
[TBL] [Abstract][Full Text] [Related]
11. Alpha 2-adrenergic receptors of the alpha 2c subtype mediate inhibition of norepinephrine release in human kidney cortex.
Trendelenburg AU; Limberger N; Rump LC
Mol Pharmacol; 1994 Jun; 45(6):1168-76. PubMed ID: 7912816
[TBL] [Abstract][Full Text] [Related]
12. Interaction of formamidine pesticides with the presynaptic alpha(2)-adrenoceptor regulating.
Altobelli D; Martire M; Maurizi S; Preziosi P
Toxicol Appl Pharmacol; 2001 May; 172(3):179-85. PubMed ID: 11312645
[TBL] [Abstract][Full Text] [Related]
13. Coupling of human alpha 2-adrenoceptor subtypes to regulation of cAMP production in transfected S115 cells.
Jansson CC; Marjamäki A; Luomala K; Savola JM; Scheinin M; Akerman KE
Eur J Pharmacol; 1994 Jan; 266(2):165-74. PubMed ID: 7908883
[TBL] [Abstract][Full Text] [Related]
14. Species orthologs of the alpha-2A adrenergic receptor: the pharmacological properties of the bovine and rat receptors differ from the human and porcine receptors.
O'Rourke MF; Iversen LJ; Lomasney JW; Bylund DB
J Pharmacol Exp Ther; 1994 Nov; 271(2):735-40. PubMed ID: 7965790
[TBL] [Abstract][Full Text] [Related]
15. Tethered yohimbine analogs as selective human alpha2C-adrenergic receptor ligands.
Bavadekar SA; Ma G; Mustafa SM; Moore BM; Miller DD; Feller DR
J Pharmacol Exp Ther; 2006 Nov; 319(2):739-48. PubMed ID: 16873606
[TBL] [Abstract][Full Text] [Related]
16. A comparison of agonist-specific coupling of cloned human alpha(2)-adrenoceptor subtypes.
Rudling JE; Richardson J; Evans PD
Br J Pharmacol; 2000 Nov; 131(5):933-41. PubMed ID: 11053214
[TBL] [Abstract][Full Text] [Related]
17. Tonic inhibitory role for cAMP in alpha(1a)-adrenergic receptor coupling to extracellular signal-regulated kinases 1/2.
Jiao X; Gonzalez-Cabrera PJ; Xiao L; Bradley ME; Abel PW; Jeffries WB
J Pharmacol Exp Ther; 2002 Oct; 303(1):247-56. PubMed ID: 12235258
[TBL] [Abstract][Full Text] [Related]
18. Protean agonism at alpha2A-adrenoceptors.
Jansson CC; Kukkonen JP; Näsman J; Huifang G; Wurster S; Virtanen R; Savola JM; Cockcroft V; Akerman KE
Mol Pharmacol; 1998 May; 53(5):963-8. PubMed ID: 9584224
[TBL] [Abstract][Full Text] [Related]
19. In vivo gene modification elucidates subtype-specific functions of alpha(2)-adrenergic receptors.
Kable JW; Murrin LC; Bylund DB
J Pharmacol Exp Ther; 2000 Apr; 293(1):1-7. PubMed ID: 10734146
[TBL] [Abstract][Full Text] [Related]
20. Ca2+ inhibition of beta-adrenergic receptor- and forskolin-stimulated cAMP accumulation in C6-2B rat glioma cells is independent of protein kinase C.
Debernardi MA; Munshi R; Brooker G
Mol Pharmacol; 1993 Mar; 43(3):451-8. PubMed ID: 8383803
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
